
GLP-1 receptor agonist
TopicHeard on podcasts recently
GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone to lower blood sugar levels, reduce appetite, and slow digestion. They are widely used in the treatment of type 2 diabetes and obesity, and are under study for other metabolic conditions. Common examples of this drug class include semaglutide, liraglutide, and tirzepatide.
Rank this week
Share of the conversation
Reach this week
Tone this week
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of GLP-1 receptor agonist per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 28 | 0.01‰ | 1 |
| Oct 24 | 0.01‰ | 1 |
| Nov 13 | 0.02‰ | 2 |
| Nov 15 | 0.02‰ | 1 |
| Nov 16 | 0.03‰ | 1 |
| Nov 20 | 0.03‰ | 2 |
Who is saying what about GLP-1 receptor agonist
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Chris Thompson14 claims on 1 show
“when you lose weight, about a third of the weight you lose would be lean mass”
Huberman Lab · Sep 21 ↗ - Scott Kanoski6 claims on 1 show
“nausea and emesis, emesis being vomiting, the most common side effects.”
Huberman Lab · Oct 12 ↗ - Dr. Gabrielle Lyon5 claims on 1 show
“decreased sex drive, fun, mood, all of those things, those are a problem”
Modern Wisdom · Sep 10 ↗
28 more with Pro.
Discussed alongside
Names that come up in the same conversations as GLP-1 receptor agonist.
Embed this
Paste this on your site to show GLP-1 receptor agonist's current trend:
<iframe src="https://podlume.ai/embed/e/glp-1-receptor-agonist" width="360" height="220" style="border:0" loading="lazy" title="GLP-1 receptor agonist on PodLume Trends"></iframe>